Figure 1From: Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso Culture and GenoType ® MTBDR plus results in patients enrolled at different times under category IV regimens. The diagram reports smear microscopy results after the re-testing of samples in Italy and M. tuberculosis Complex results by GenoType MTBDRplus ® and microbiology analyses. Patients are divided in two groups on the basis of the enrolment time in the study (beginning of the therapy, M0; during follow-up, M1–M30). The percentage of resistant cases as "any resistance" is also reported (R).Back to article page